Jason R. Pettus, MD, BS
Title(s)
Associate Professor of Pathology and Laboratory Medicine
Associate Professor of Medicine
Additional Titles/Positions/Affiliations
Pathology Gross Room Medical Director
Diplomate of the American Board of Pathology
Department(s)
Pathology and Laboratory Medicine
Medicine
Education
B.S. Saint Louis University | 2004
M.D. University of Missouri-Columbia | 2008
Anatomic and Clinical Pathology Residency
Dartmouth-Hitchcock Medical Center | 2012
Fellowship in Head & Neck and Genitourinary Surgical Pathology
Massachusetts General Hospital | 2013
Programs
Dartmouth Cancer Center
Academic Analytics
View Profile
Contact Information
One Medical Center Drive
Lebanon NH 03756
Office: 603-650-7468
Phone: 603-650-7468
Fax: 603-650-7214
Email: Jason.R.Pettus@Dartmouth.edu
Professional Interests
HPV-related oropharyngeal cancer, thyroid cancer, prostate cancer, kidney cancer, bladder cancer, pathology informatics, molecular pathology.
Courses Taught
Scientific Basis of Medicine - Reproduction Course presenter, Urologic pathology
Pathology Small Group Discussions
Biography
Dr. Pettus joined faculty in 2013 primarily as a pathologist clinician-teacher. He is interested in collaborative research related to head and neck, urologic, and endocrine pathology.
Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study. Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study. Shared chromosome 21q loss in a mixed subtype renal cell carcinoma: composite or collision tumor? The art of specimen orientation: Two-dimensional maps for oropharynx squamous cell carcinoma. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3. Genomic profile of Pancoast syndrome due to hepatocellular carcinoma: A case report. A case of IgM nephropathy secondary to NSAIDs. Highlighting the Diversity of Desmoplastic Small Round Cell Tumor: A Case Series. In Reply. Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib. |